TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $1.70B2017: $2.49B2018: $3.05B2019: $4.16B2020: $6.21B2021: $7.57B2022: $8.93B2023: $9.87B2024: $11.02B2025: $12.00B$12.00B
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$12.00B+8.9%
2024$11.02B+11.7%
2023$9.87B+10.5%
2022$8.93B+17.9%
2021$7.57B+22.1%
2020$6.21B+49.1%
2019$4.16B+36.6%
2018$3.05B+22.5%
2017$2.49B+46.2%
2016$1.70B—